ghk cu peptide and nad+ together Molecular structure of the tripeptide GHK-Cu. In solution lysine GHK-Cu Copper Peptide

Log your doses, timing, and subjective response

The peptide operates through a highly specific mechanism: it disrupts the interaction between FOXO4 transcription factor and the p53 tumor suppressor protein

Effects are cumulative, not immediate

"Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 24 mg for weight management: a randomised, controlled, phase 1b trial"

[8] Retatrutide is the triple-agonist expression of that trajectory, engineered as one peptide that hits GIP, GLP-1, and glucagon receptors simultaneously

The work below comes from preclinical studies, not from proven effects in people